CDC IIS Update – Logic Specification for ACIP Recommendations

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to Registry (IIS): Homepage for Centers for Disease Control and Prevention (CDC).

This information has recently been updated and is now available.

Logic Specification for ACIP Recommendations
A single, implementation-neutral foundation for developing and maintaining CDS engines

CDC VTrckS newsletter now online

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to VTrckS: Vaccine Tracking System for Centers for Disease Control and Prevention (CDC).

The latest newsletter is now available online.

CDC – Prevnar13* and Pneumovax* (PSSV23) Recommendations Update

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to either the Healthcare Professionals’ or Program Managers Portal of the CDC web site.

This message serves to inform you about the new ACIP recommendations to give PCV13 (Prevnar 13) to high-risk adults and includes reviews on existing PPSV23 (Pneumovax) recommendations for adults.

Now on Medscape, CDC expert Tamara Pilishvili, MPH, talks about the new Advisory Committee on Immunization Practices (ACIP) recommendations to give PCV13 (Prevnar 13) to high-risk adults and reviews existing PPSV23 (Pneumovax) recommendations for adults. This overview is a must-see for every doctor, nurse, and health care provider who provides medical care to adults.

Healthcare providers should follow these overarching recommendations:

  • Adults 19 years of age or older with immunocompromising conditions, functional or anatomic asplenia, CSF leaks, or cochlear implants, and who have not previously received PCV13 or PPSV23, should receive a dose of PCV13 first followed by a dose of PPSV23 at least 8 weeks later. Subsequent doses of PPSV23 should follow current PPSV23 recommendations for high risk adults.
  • Adults 19 years of age or older with the aforementioned conditions (functional or anatomic asplenia, immunocompromising conditions, or those with CSF leaks or cochlear implants) who have previously received one or more doses of PPSV23 should be given a dose of PCV13 one or more years after the last PPSV23 dose was received. For those who require additional doses of PPSV23, the first such dose should be given no sooner than 8 weeks after PCV13 and at least 5 years since the most recent dose of PPSV23.
  • Those who received one or more doses of PPSV23 before age 65 years for any indication should receive another dose of the vaccine at age 65 years or older if at least 5 years have elapsed since their previous PPSV23 dose. If a dose of PPSV23 was received at age 65 years or later, no additional doses of PPSV23 are recommended.
  • PPSV23 recommendations remain the same for those 65 years and older and those who are immunocompetent with chronic medical conditions, such as diabetes or heart disease.

To learn more about pneumococcal disease and vaccines, visit the resources listed below.

Web Sites

ACIP Recommendations

Video

Centers for Disease Control and Prevention (CDC) Registry (IIS): Homepage Update

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to Registry (IIS): Homepage for Centers for Disease Control and Prevention (CDC).
This message serves to inform you that the following information has recently been added and is now available.

Two-Dimensional (2D) Vaccine Barcoding
Provides information on the need for and potential impact of 2D barcoding on EHRs and IIS, describes CDC’s 2D barcode pilot project, and provides links to additional resources.

CDC ACIP: Home Page Update

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to CDC’s ACIP web site email subscription service. This email serves to inform you that the 2013 February ACIP meeting registration is now available. You have until Feb 4th to register.

NOTE: If you attempted to register for the next ACIP meeting at some point earlier today, you’ll need to do so again as the registration system just went live a few moments ago.

You do not need to register if you will be watching the meeting via the webcast. Instructions for the webcast will be posted a few days before the next meeting.

New CDC Web Page: Resources for Educating Adult Patients about Vaccines

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to one of the Vaccines & Immunization’s CDC email subscription services.

This message serves to inform you that in the “spotlight” are Resources for Educating Adult Patients about Vaccines
http://www.cdc.gov/vaccines/hcp/patient-ed/adults/index.html

CDC ACIP: Provisional Recommendations Update

Having trouble viewing this email? View it as a Web page.

Bookmark and Share

You are subscribed to CDC’s ACIP: Provisional Recommendations email subscription service. This information has recently been updated and is now available.

The provisional recommendations have been removed from the site as the MMWR has been published: